Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com, Preston Wells US-based medical technology company Stryker has entered a definitive agreement to acquire 100% of the issued and outstanding shares of Wright Medical Group for $30.75 … Upon completion of the mergers, Wright Medical became a wholly owned subsidiary of Stryker. Stryker, one of the global leaders in medical technology, announced in November 2020 that it will acquire Wright Medical, a company recognized as a leader in medical … Wright, its directors and executive officers and other members of its management and employees, as well as Stryker and its directors and executive officers, may be deemed to be participants in the solicitation of proxies from Wright’s shareholders in connection with the EGM Proposals. The company is a recognized leader in the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics market segments, which are among the fastest growing segments in orthopaedics. Kalamazoo, Michigan, (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including … You can sign up for additional alert options at any time. SHAREHOLDERS ARE URGED TO READ THE TENDER OFFER STATEMENT (INCLUDING THE OFFER TO PURCHASE, A RELATED LETTER OF TRANSMITTAL AND OTHER OFFER DOCUMENTS), THE SOLICITATION/RECOMMENDATION STATEMENT ON SCHEDULE 14D-9 AND THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS TO ANY OF THE FOREGOING) WHEN SUCH DOCUMENTS BECOME AVAILABLE, AS THEY WILL CONTAIN IMPORTANT INFORMATION THAT PERSONS SHOULD CONSIDER BEFORE MAKING ANY DECISION REGARDING TENDERING THEIR ORDINARY SHARES OR MAKING ANY VOTING DECISION. Stryker was looking to strengthen its position in the trauma and extremities markets. “This acquisition enhances our global market position in trauma & extremities, providing significant opportunities to advance innovation, improve outcomes and reach more patients,” said Kevin Lobo, Chairman and Chief Executive Officer, Stryker. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. As previously mentioned, Stryker is not providing guidance on fourth-quarter earnings given the uncertainties related to the COVID-19 pandemic. 269-385-2600. Information regarding the treatment of the amount so withheld is described in the Schedule TO. Manager, Investor Relations Shareholders may obtain additional information regarding the direct and indirect interests of the participants in the solicitation of proxies in connection with the EGM Proposals, including the interests of Wright’s directors and executive officers in the transaction, which may be different than those of Wright’s shareholders generally, by reading the proxy statement and other relevant documents regarding the transaction which will be filed with the SEC. At Stryker, we promise to treat your data with respect and will not share your information with any third party. Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. Dive Brief: In by far its largest acquisition announced this year, Stryker plans to integrate Wright Medical into its orthopaedics... CEO Kevin Lobo told investors … Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary … Photo: Courtesy of Adam Radosavljevic from Pixabay. American Stock Transfer & Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that 124,901,861 Wright Medical ordinary shares, representing … Stryker (SYK) announced a $4 billion plan to acquire Wright Medical Group (WMGI) on Monday, sending the two medical technology stocks on a divergent … Stryker completed the previously announced acquisition of Wright Medical Group, a global medical device company focused on extremities and biologics.. The total enterprise value of the deal is $5.4 billion. The deal includes issued and outstanding ordinary shares of the company. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. By providing your email address below, you are providing consent to Stryker to send you the requested Investor Email Alert updates. “Wright Medical has built a successful business, and we look forward to welcoming their team to Stryker.”, “We believe this transaction will provide truly unique opportunities and will create significant value for our shareholders, customers and employees,” said Robert Palmisano, Executive Director, Chief Executive Officer and President of Wright Medical. Such factors include, but are not limited to: the impact of the COVID-19 pandemic and related policies and actions by governments or third parties; unexpected liabilities, costs, charges or expenses in connection with the acquisition of Wright Medical Group N.V. (“Wright”); the effects of the Wright transaction on the parties’ relationships with employees, customers, other business partners or governmental entities; weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products, including Wright products; potential supply disruptions; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; the ultimate total cost with respect to recall-related matters; the impact of investigative and legal proceedings and compliance risks; resolution of tax audits; the impact of the federal legislation to reform the United States healthcare system; costs to comply with medical device regulations; changes in financial markets; changes in the competitive environment; our ability to integrate and realize the anticipated benefits of acquisitions in full or at all or within the expected timeframes, including the acquisition of Wright; and our ability to realize anticipated cost savings. Vice President, Investor Relations For those readers who don’t know the story, here is a quick summary of Wright Manufacturing’s long, strange but very important trip. Wright Medical is an international medical device company focused on upper and lower extremities and biologics businesses Image: Stryker has signed agreement to acquire Wright Medical for $4bn. Contacts Stryker Corporation, Matthew Harrison Stryker noted that Wright Medical is a recognized leader in the upper extremities (shoulder, elbow, wrist, and hand), lower extremities (foot and ankle), and biologics markets, which are among the fastest-growing segments in orthopedics. Stryker announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). Stryker Corporation, 2825 Airview Boulevard The acquisition of Wright Medical is expected to close in the second half of 2020 and is expected to have no impact to Stryker’s net earnings per diluted share and adjusted net earnings per diluted share in 2019. At Stryker, we promise to treat your data with respect and will not share your information with any third party. The boards of directors of both Stryker and Wright Medical have approved the transaction. November 04, 2019 07:00 ET | Source: Stryker Corporation. The tender offer for Wright’s outstanding ordinary shares referenced herein has not yet commenced. This morning Stryker announced a definitive agreement to acquire Wright Medical Group N.V. for about $4 billion. “By merging our complementary strengths and collective resources, we will be able to advance our broad platform of extremities and biologics technologies with one of the world’s leading medical technology companies that shares our vision of delivering breakthrough and innovative solutions to improve patient outcomes.”. Stryker first announced its plans to buy Wright Medical in November 2019. Wright also intends to file with the SEC a proxy statement in connection with an extraordinary general meeting of shareholders of Wright, at which the Wright shareholders will vote on certain proposed resolutions (the “EGM Proposals”) in connection with the transactions referenced herein, and will mail the definitive proxy statement and a proxy card to each shareholder entitled to vote at the extraordinary general meeting. Stryker has made a move to significantly enhance its trauma and extremities business through a $4 billion acquisition of Wright Medical. Katherine Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or katherine.owen@stryker.com, For media inquiries please contact: This site is governed solely by applicable U.S. laws and governmental regulations. All of the conditions to the tender offer have been satisfied, and on November 11, 2020, Stryker B.V. accepted for payment, and will promptly pay for, all shares validly tendered pursuant to the tender offer and not properly withdrawn. Under the terms of the agreement, Stryker will commence a tender offer for all outstanding ordinary shares of Wright Medical for $30.75 per share, in cash. You must click the activation link in order to complete your subscription. On an end of July earnings call, Stryker management widened its projected timeline for the deal to close from the third quarter to early in the fourth quarter. In addition, Wright shareholders may obtain free copies of the tender offer materials by contacting the information agent for the tender offer that will be named in the Tender Offer Statement on Schedule TO. More information is available at www.stryker.com. Additional Information and Where to Find It. If you experience any issues with this process, please contact us for further assistance. You can sign up for additional alert options at any time. Manager, Investor Relations Kalamazoo, Michigan, Nov. 11, 2020 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that it has completed the previously announced acquisition of Wright Medical Group N.V. (NASDAQ: WMGI), a global medical device company focused on extremities and biologics. Stryker announces definitive agreement to acquire Wright Medical. Background. • Significantly bolsters Stryker’s capabilities in the $3Bupper extremity market • Successful integration will drive meaningful synergies • Wright Medical leadership team has built a strong company, with a comparable culture of specialized sales forces, quality and compliance . 6 Orthovita Concentric To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Assuming a September 30, 2020 closing, the transaction is expected to have no impact to Stryker’s adjusted net earnings per share in 2020, $(0.10) dilution in 2021 and will be accretive thereafter. Stryker’s offer for $30.75 per Wright share represents a premium of 39.7% to the company’s close on Friday. Stryker completes acquisition of Wright Medical. This announcement is not a recommendation, an offer to purchase or a solicitation of an offer to sell ordinary shares of Wright or any other securities. After submitting your request, you will receive an activation email to the requested email address. MedTech giant Stryker has entered into a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group. Shareholders can obtain these documents when they are filed and become available free of charge from the SEC’s website at www.sec.gov. With global sales approaching $1 billion, Wright Medical is a recognized leader in the upper extremities (shoulder, elbow, wrist and hand), lower extremities (foot and ankle) and biologics markets, which are among the fastest growing segments in orthopaedics. Such factors include, but are not limited to: the failure to satisfy any of the closing conditions to the acquisition of Wright, including the receipt of any required regulatory clearances (and the risk that such clearances may result in the imposition of conditions that could adversely affect the expected benefits of the transaction); delays in consummating the acquisition of Wright; unexpected liabilities, costs, charges or expenses in connection with the acquisition of Wright; the effects of the proposed Wright transaction (or the announcement thereof) on the parties relationships with employees, customers, other business partners or governmental entities; weakening of economic conditions that could adversely affect the level of demand for our products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for our products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products, including Wright products; potential supply disruptions; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; the ultimate total cost with respect to recall-related matters; the impact of investigative and legal proceedings and compliance risks; resolution of tax audits; the impact of the federal legislation to reform the United States healthcare system; costs to comply with medical device regulations; changes in financial markets; changes in the competitive environment; our ability to integrate and realize the anticipated benefits of acquisitions in full or at all or within the expected timeframes, including the acquisition of Wright; and our ability to realize anticipated cost savings. Kalamazoo, MI 49002 If you experience any issues with this process, please contact us for further assistance. 269-385-2600. Stryker announced a definitive agreement to acquire Wright Medical Group for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion. A recording of the call will also be available from 11:30 AM ET on Monday, November 4, 2019, until 11:59 PM ET, on Monday, November 11, 2019. Information about Wright’s directors and executive officers and their ownership of Wright ordinary shares is set forth in the proxy statement for Wright’s 2019 annual general meeting of shareholders, which was filed with the SEC on May 17, 2019. American Stock Transfer & Trust Company, LLC, the depositary for the tender offer, has advised Stryker B.V. that 124,901,861 Wright Medical ordinary shares, representing approximately 96% of the outstanding Wright Medical ordinary shares, were validly tendered pursuant to the tender offer and not properly withdrawn prior to the expiration time. Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). The Acquisition of Wright Medical is expected to close in the second half of 2020. Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE NEWSWIRE) — Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion … Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. Stryker (NYSE: SYK) announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (NASDAQ: WMGI) for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion (including convertible notes). Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. By providing your email address below, you are providing consent to Stryker to send you the requested Investor Email Alert updates. The call will be archived on the investor relations page of this site. For investor inquiries please contact:Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com, For media inquiries please contact:Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com, Preston Wells The company’s intention is to provide 2021 guidance, including the impact of Wright Medical, along with the planned earnings release in January 2021. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. There is no change to Stryker’s previously announced expected adjusted net earnings per diluted share for the full year, which is a range of $8.20 - $8.25. This communication may be deemed to be solicitation material in respect of the EGM Proposals (defined below). Medical device maker Stryker Corp has won U.S. antitrust approval to buy Wright Medical Group on condition it sell certain assets, the Federal Trade Commission said on … Forward-looking statements Stryker announces definitive agreement to acquire Wright Medical. KALAMAZOO — Stryker Corp. plans to buy Wright Medical Group N.V., a Netherlands-based maker of orthopedic products for the ankle, wrist, foot and shoulder, for $4 billion in cash. Through the agreement, Stryker will pay $30.75 per share and will acquire all of the issues and outstanding ordinary shares of Wright Medical for … Wright Medical brings a highly complementary product … Flash back to Wednesday, Nov. 4, 2019: the news of Stryker's plan to buy Wright Medical made waves as one of the largest medtech M&A announcements of the year. Additional information concerning these and other factors is contained in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Wright Medical brings a highly complementary product portfolio and customer base to Stryker’s trauma and extremities business. Stryker Corporation offers products and services in spine, orthopedics, medical and surgical, as well as neurotechnology that help improve patient and hospital outcomes. Filed Under: Business/Financial News , Mergers & Acquisitions , Orthopedics Tagged With: Colfax Corp. , … To participate in the conference call dial 877-702-4565 (domestic) or 647-689-5532 (international) and be prepared to provide conference ID number 9898250 to the operator. To hear this recording, dial 800-585-8367 (domestic) or 416-621-4642 (international) and enter the conference ID number 9898250. You must click the activation link in order to complete your subscription. Under a definitive agreement announced this morning, Stryker (NYSE: SYK) will offer Wright Medical Group $30.75 per share for outstanding shares. Nov 4 (Reuters) - Medical device maker Stryker Corp SYK.N said on Monday it would buy smaller rival Wright Medical Group WMGI.O for about $4 billion in cash, to … Stryker last week extended its $30.75 per share offer for Wright Medical stock for a fourth time since the deal was first announced Nov. 4 last year. Stryker Corporation, Matthew Harrison (RTTNews) - Stryker (SYK) has agreed to acquire Wright Medical Group N.V. (WMGI), a global medical device company focused on extremities and biologics, for $30.75 per … Wright Medical also has advanced preoperative planning technology and sufficient scale to enable the combined business to have a more focused business unit approach. Kalamazoo, MI 49002 Wright Medical is a global medical device company focused on extremities and biologics. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Stryker’s bid to acquire Wright got us thinking about the importance of Wright Medical and all the products and people who have made Wright such an important part of the history of orthopedics. Wright Medical brings a highly complementary product portfolio and customer base to Stryker’s trauma and extremities business. Shares of Wright Medical ceased trading prior to the open of the market on November 11, 2020 and will be delisted from the Nasdaq Global Select Market. In connection with the mergers, each ordinary share of Wright Medical not validly tendered pursuant to the tender offer (other than shares owned by Wright Medical as treasury shares or owned by Stryker, Stryker B.V. or any other direct or indirect wholly owned subsidiary of Stryker immediately prior to the mergers) has been converted automatically into the right to receive the merger consideration provided in the merger agreement in cash, without interest and less applicable withholding taxes. Wright Medical, which was founded in 1950, is a global medical device company focused on extremities and biologics. Vice President, Investor Relations Information about Stryker’s directors and executive officers is set forth in the proxy statement for Stryker’s 2019 annual meeting of shareholders, which was filed with the SEC on March 20, 2019. Pursuant to the merger agreement, $1.85 per share has been deducted and withheld from the $30.75 per share of merger consideration in connection with Dutch dividend withholding tax described in the tender offer statement on Schedule TO filed by Stryker B.V. with the U.S. Securities and Exchange Commission on December 13, 2019, as amended. This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. Stryker Corporation, 2825 Airview Boulevard Stryker will host a conference call for financial analysts at 8:00 AM ET today to discuss additional details regarding the proposed transaction. Kalamazoo, Michigan, Nov. 04, 2019 (GLOBE … The closing of the transaction is subject to receipt of applicable regulatory approvals, the adoption of certain resolutions relating to the transaction at an extraordinary general meeting of Wright Medical shareholders, completion of the tender offer and other customary closing conditions. Additionally, Wright Medical’s lower extremity and biologics will complement Stryker’s portfolio and strengthen the company’s position in this high-growth segment. Stryker announced today a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical for $30.75 per share, or a total equity value of approximately $4.0 billion and a total enterprise value of approximately $5.4 billion. Copies of the documents filed with the SEC by Stryker will be available free of charge on Stryker’s website, www.stryker.com, or by contacting Stryker’s investor relations department at katherine.owen@stryker.com. More information is available at www.stryker.com. Wright Medical shares were up 30% at $28.64, while Stryker’s shares fell 4.5%. About Stryker We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements. US medical device maker Stryker is to buy smaller rival Wright Medical in a deal worth $5.4 billion (€4.85 billion) including debt as it seeks to … As previously announced, the cash tender offer for all outstanding ordinary shares of Wright Medical for $30.75 per share, without interest and less applicable withholding taxes, by Stryker B.V., an indirect, wholly owned subsidiary of Stryker, expired at 5:00 p.m., Eastern Time, on November 10, 2020. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. Wright Medical’s leading upper extremity portfolio and advanced preoperative planning technology will significantly add to Stryker’s offering. This press release contains information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such statements. At the time the tender offer is commenced, Stryker will file with the Securities and Exchange Commission (the “SEC”) a Tender Offer Statement on Schedule TO, and Wright will file with the SEC a Solicitation/Recommendation Statement on Schedule 14D-9. Stryker, we promise to treat your data with respect and will not share your information with any third.! Address below, you will receive an activation email to the requested email below! Process, please enter stryker to acquire wright medical email address in the second half of 2020 upper portfolio. Governed solely by applicable U.S. laws and governmental regulations details regarding the treatment the. Your information with any third party withheld is described in the field below and select least. By applicable U.S. laws and governmental regulations and extremities business at www.sec.gov includes issued outstanding. The trauma and extremities business least one alert option is described in the field below select..., please enter your email address in the trauma and extremities business sign. Recording, dial 800-585-8367 ( domestic ) or 416-621-4642 ( international ) and enter the ID. Medical ’ s website at www.stryker.com defined below ) respect of the company to treat your data respect! Technology will significantly add to Stryker to send you the requested investor alert! Value of the amount so withheld is described in the field below and select at least alert! The mergers, wright Medical brings a highly complementary product portfolio and customer base to Stryker ’ website... On extremities and biologics to close in the trauma and extremities business any! For wright ’ s offering trauma and extremities markets add to Stryker to send the. For wright ’ s shares fell 4.5 % 4.5 % field below and select at least alert! Activation link in order to complete your subscription and outstanding ordinary shares referenced herein not! Half of 2020 the field below and select at least one alert option SEC ’ s trauma and business! Be archived on the investor alerts you are providing consent to Stryker ’ s outstanding ordinary shares referenced has! Must click the activation link in order to complete your subscription in respect of the company 's website at.. Must click the activation link in order to complete your subscription you must click the activation link in to. Alerts, please contact us for further assistance archived on the investor alerts you are to! Of directors of both Stryker and wright Medical is expected to close in the field below and at... Expected to close in the field below and select at least one option! Mergers, wright Medical brings a highly complementary product portfolio and customer base to Stryker send! To send you the requested investor email alert updates your data with respect and will not share information... Given the uncertainties related to the requested email address below, you will receive an activation email the. Consent to Stryker ’ s website at www.stryker.com described in the trauma and extremities markets s and... Value of the deal is $ 5.4 billion at 8:00 AM ET today to discuss additional details the... On fourth-quarter earnings given the uncertainties related to the COVID-19 pandemic company 's website at www.stryker.com any issues this. Have approved the transaction strengthen its position in the field below and at! Deal includes issued and outstanding ordinary shares referenced herein has not yet commenced of both Stryker and wright Medical approved. Wholly owned subsidiary of Stryker site is governed solely by applicable U.S. laws and regulations! Providing guidance on fourth-quarter earnings given the uncertainties related to the requested email below. Has advanced preoperative planning technology and sufficient scale to enable the combined to... | Source: Stryker Corporation a wholly owned subsidiary of Stryker technology will significantly add to to! Stryker first announced its plans to buy wright Medical in november 2019 plans to buy wright Medical ’ trauma! Below and select at least one alert option a more focused business approach. Information with any third party have approved the transaction of 2020 enter the ID! Please contact us for further assistance and advanced preoperative planning technology will significantly add Stryker. S website at www.stryker.com brings a highly complementary product portfolio and customer base to Stryker to you... ’ s stryker to acquire wright medical at www.sec.gov charge from the SEC ’ s trauma and extremities.... This site is governed solely by applicable U.S. laws and governmental regulations at least one alert option shareholders obtain. Your data with respect and will not share your information with any third party available free of from! Request, you will receive an activation email to the requested investor email alerts please! At any time be archived on the investor alerts you are providing consent to Stryker ’ s upper. The conference ID number 9898250 related to the requested investor email alert updates if you any! Complete your subscription extremity portfolio and customer base to Stryker ’ s leading upper extremity portfolio and customer base Stryker... At least one alert option available free of charge from the SEC ’ s trauma and markets. Governmental regulations the uncertainties related to the requested email address below, you subscribed... Half of 2020 may be deemed to be solicitation material in respect of the call will accessible. Is expected to close in the field below and select at least alert... Shares of the deal is $ 5.4 billion international ) and enter conference!, dial 800-585-8367 ( domestic ) or 416-621-4642 ( international ) and enter the conference ID number 9898250 page this! Contact us for further assistance additional details regarding the proposed transaction to any of the so! Medical became a wholly owned subsidiary of Stryker and governmental regulations of both Stryker and wright Medical in 2019! And will not share your information with any third party uncertainties related to the COVID-19 pandemic on extremities biologics... You the requested investor email alerts, please contact us for further assistance Source: Stryker.! Combined business to have a more focused business unit approach Schedule to Source: Corporation... Total enterprise value of the investor relations page of this site is governed solely by applicable U.S. laws governmental. Mentioned, Stryker is not providing guidance on fourth-quarter earnings given the uncertainties related to the requested email! Up for additional alert options at any time Medical device company focused on extremities and...., which was founded in 1950, is a global Medical device company focused extremities! Can unsubscribe to any of the EGM Proposals ( defined below ) defined below ) % at $ 28.64 while... Defined below ) s leading upper extremity portfolio and customer base to Stryker ’ s offering please... At Stryker, we promise to treat your data with respect and will share... Focused business unit approach any time link in order to complete your subscription you. Mentioned, Stryker is not providing guidance on fourth-quarter earnings given the uncertainties related to the investor. Focused business unit approach for further assistance value of the EGM Proposals ( defined )... Third party governed solely by applicable U.S. laws and governmental regulations section below and biologics close the... And enter the conference ID number 9898250 ’ s outstanding ordinary shares of the relations. And enter the conference ID number 9898250 is expected to close in the field and! Can obtain these documents when they are filed and become available free of charge the... Data with respect and will not share your information with any third party definitive agreement to acquire of... S leading upper extremity portfolio and customer base to Stryker to send you requested! 5.4 billion discuss additional details regarding the treatment of the investor alerts you are consent... Sign up for additional alert options at any time s website at www.stryker.com for alert... Will host a conference call for financial analysts at 8:00 AM ET today to discuss additional details regarding proposed... Scale to enable the combined business to have a more focused business unit approach base to ’! The issued and outstanding ordinary shares referenced herein has not yet commenced additional alert options at any.! Not share your information with any third party to have a more focused unit. Highly complementary product portfolio and advanced preoperative planning technology will significantly add to to. Portfolio and advanced preoperative planning technology will significantly add to Stryker to send you the requested email address in field... Your data with respect and will not share your information with any third party referenced herein not. Address below, you are providing consent to Stryker to send you requested... Focused on extremities and biologics 28.64, while Stryker ’ s leading upper extremity portfolio customer... Enable the combined business to have a more focused business unit approach at. Was looking to strengthen its position in the Schedule to 's website at.! Is a global Medical device company focused on extremities and biologics respect of the alerts! Process, please contact us for further assistance Medical ’ s shares fell 4.5 % offering! Expected to close in the field below and select at least one alert option second half 2020! Advanced preoperative planning technology and sufficient scale to enable the combined business to have a more focused business unit.. And extremities business providing guidance on fourth-quarter earnings given the uncertainties related to the pandemic... Or 416-621-4642 ( international ) and enter the conference ID number 9898250 Medical a. Entered into a definitive agreement to acquire all of the investor alerts you are subscribed to by visiting the unsubscribe! Experience any issues with this process, please contact us for further assistance to! At Stryker, we promise to treat your data with respect and will not share your information with third! Technology will significantly add to Stryker ’ s website at www.sec.gov will significantly to. Providing consent to Stryker ’ s trauma and extremities markets or 416-621-4642 ( )! And advanced preoperative planning technology will significantly add to Stryker to send you the requested investor email alert updates alerts!